IRIDEX Corporation (IRIX): Price and Financial Metrics

IRIDEX Corporation (IRIX): $3.02

0.16 (-5.03%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

IRIX Price/Volume Stats

Current price $3.02 52-week high $3.65
Prev. close $3.18 52-week low $1.31
Day low $2.96 Volume 38,092
Day high $3.24 Avg. volume 33,431
50-day MA $2.76 Dividend yield N/A
200-day MA $2.46 Market Cap 49.08M

IRIX Stock Price Chart Interactive Chart >


IRIDEX Corporation (IRIX) Company Bio


IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. The company was founded in 1989 and is based in Mountain View, California.


IRIX Latest News Stream


Event/Time News Detail
Loading, please wait...

IRIX Latest Social Stream


Loading social stream, please wait...

View Full IRIX Social Stream

Latest IRIX News From Around the Web

Below are the latest news stories about IRIDEX CORP that investors may wish to consider to help them evaluate IRIX as an investment opportunity.

Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation

MOUNTAIN VIEW, Calif., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today announced its successful advocacy for revision of the recently issued Medicare Local Coverage Determinations (LCDs) for Cyclophotocoagulation (CPC). During the last few days, the five Medicare Administrative Contractors (MACs) t

Yahoo | November 27, 2023

Iridex Reports Third Quarter 2023 Financial Results and Business Update

MOUNTAIN VIEW, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the third quarter ended September 30, 2023 and provided a business update. Recent Business Updates Generated total revenue of $12.9 million, representing flat sequential quarter revenue and a decre

Yahoo | November 14, 2023

Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023

The Company also announced plans to present at Stifel Healthcare ConferenceMOUNTAIN VIEW, Calif., Nov. 13, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will host its third quarter financial results conference call on November 14, 2023 and plans to participate in the upcoming Stifel Healthcare Conference on November 15, 2023 in New York, N

Yahoo | November 13, 2023

Iridex to Report Third Quarter Financial Results on November 14, 2023

MOUNTAIN VIEW, Calif., Oct. 26, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal diseases, today announced the Company will release financial results for the third quarter of 2023 after the close of trading on Tuesday, November 14, 2023. About IridexIridex Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical sy

Yahoo | October 26, 2023

IRIDEX's (NASDAQ:IRIX) growing losses don't faze investors as the stock surges 18% this past week

One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger...

Yahoo | October 10, 2023

Read More 'IRIX' Stories Here

IRIX Price Returns

1-mo 27.97%
3-mo 8.63%
6-mo -4.73%
1-year 37.27%
3-year -59.30%
5-year -41.47%
YTD 7.47%
2023 39.80%
2022 -67.10%
2021 143.43%
2020 12.56%
2019 -52.55%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!